Health
US FDA delays decision on Lilly Alzheimer’s drug
The US Food and Drug Administration has deferred a decision on Eli Lilly’s experimental early-stage Alzheimer’s disease treatment and will hold a meeting of outside
Alabama’s Republican governor signs IVF protection bill into law
Alabama Governor Kay Ivey on Wednesday signed into law a measure aimed at protecting in vitro fertilisation after the state Supreme Court ruled that frozen
A cancer-causing chemical has been found in Clinique and Clearasil acne products
High levels of the carcinogenic chemical benzene have been found in some acne products from brands such as Estee Lauder’s Clinique, Target’s Up & Up
Dengue fever outbreaks are on the rise in Brazil
Cases of a mosquito-borne disease have soared in Brazil during the hot rainy season, prompting authorities to take emergency measures. The São Paulo state health
Ozempic reduces the severity of liver disease in people with HIV
A weekly injection of semaglutide is safe and reduces liver fat by 31% in people with HIV and some type of liver disease, data from
US to accelerate some payments to hospitals after UnitedHealth hack
The US government said on Tuesday it would accelerate Medicare and Medicaid payments to some hospitals affected by the hack of insurance company UnitedHealth’s technology
US FDA has authorised the first over-the-counter continuous glucose monitor
The health regulator said the US Food and Drug Administration has authorised the Dexcom Device, making it the first continuous glucose monitor available without a
The US FDA has approved the eye drug Eyenovia
The US Food and Drug Administration has approved Eyenovia eye drops to reduce inflammation and pain in patients who have undergone eye surgery, Taiwan-based Formosa
French lawmakers have made abortion a constitutional right
France on Monday enshrined the right to abortion in its constitution. MPs and senators overwhelmingly backed the move, by 780 votes to 72, in an
GSK’s new HIV drug formulation may support longer dosing intervals
GSK said the new HIV prevention and treatment formulation could potentially be administered at least every four months, an improvement over the previous requirement of